Merck KGaA and South Korea’s Samsung BioLogics are deepening a collaboration even as Samsung reported an operating profit for the first time.
Shortages of drugs produced in Puerto Rico are beginning to materialize after hurricanes Irma and Maria wreaked havoc on production on the island.
There’s no stopping time…but these Patient Recruitment & Retention tactics can help overcome trial delays. Our global late-stage study expert discusses…
Pfizer has sold another Hospira plant, its second in eight weeks, this one a high containment API facility in Boulder, Colorado.
Indian CDMO Piramal Pharma Solutions is beefing up its global API production, including in the U.S., where it has expanded in recent years.
Budding CDMO Avara Pharmaceutical Services has bought a solid dose facility in France from AstraZeneca, its third plant acquisition in three months.
AmerisourceBergen has pled guilty and agreed to pay $260 million to settle a federal case over its sales of cancer meds from an unregistered facility.
Generic API maker Cambrex said it will begin a $3.5 million project to improve wastewater processing capabilities at its facility in Sweden.
GlaxoSmithKline has a deal to sell a consumer health products plant in the U.S. to CDMO Avara Pharmaceutical Services.
Fresenius Kabi, which has been spending heavily to broaden its capabilities, has started construction on a $250 million project in Illinois.
Roche has struck a deal to unload a plant in Spain to Recipharm, a move that will save 200 jobs as it sheds unneeded small-molecule facilities.